Navigation Links
Elsevier introduces Cardiac Electrophysiology Clinics

Philadelphia, 27 April 2010 - Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces a new addition to the Clinics of North America series Cardiac Electrophysiology Clinics.

Under the expert guidance of Consulting Editors Dr. Ranjan Thakur and Dr. Andrea Natale, each issue is devoted to a single topic that covers the most significant concerns in this field. According to Dr. Thakur, the goal of Cardiac Electrophysiology Clinics is "to provide comprehensive reviews of contemporary issues of interest to clinicians. Electrophysiologists as well as other cardiologists and physicians caring for patients with arrhythmias will find these issues helpful in clinical decision making."

Dr. Thakur is Professor of Medicine and Program Director of the Cardiac Electrophysiology Fellowship at Michigan State University and Director of the Arrhythmia Service at the Thoracic and Cardiovascular Institute, Sparrow Health System, in Lansing, Michigan. Dr. Natale is Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin Texas.

The initial issues of this quarterly publication feature the following topics:

  • Sudden Cardiac Death: Despite emergency medical response systems, long-term survival from out-of-hospital cardiac arrest remains poor in most US cities. This issue covers the full spectrum of issues related to sudden cardiac death, including the epidemiology of sudden cardiac death, advances in CPR, the implantable cardiac defibrillator (ICD), and ventricular tachycardia ablation.

  • Epicardial Interventions in Electrophysiology: Epicardial ablation is a relatively new technique that is less invasive than traditional surgical ablation. It shows promise in certain patient populations. This issue of Cardiac Electrophysiology Clinics is one of the first collections of articles on this cutting edge technique.

  • Advances in Arrhythmia Analyses: A Case-Based Approach: This issue is a valuable tool to help electrophysiologists interpret complex ECGs so they can better understand arrhythmia mechanisms. Organized by cases, this issue illustrates many of the classic electrocardiographic findings and phenomena that every electrophysiologist should know.

  • Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Arrhythmogenic right ventricular dysplasia is an inherited heart muscle disorder that may cause abnormal electrical heart rhythms and weakening of the pumping action of the heart, resulting in sudden death. The electrocardiograph (EKG) is used to diagnose the disease, so it is important for cardiac electrophysiologists to be familiar with the disease and to be able to recognize it on the EKG.

  • Advances in Antiarrhythmic Drug Therapy: Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators. Antiarrhythmic agents, which are pharmaceutical agents used to suppress fast rhythms of the heart (cardiac arrhythmias), represent another treatment option. This issue summarizes the most current thinking on the role of pharmaceuticals in relation to other types of treatment, helping electrophysiologists to determine the best method for managing their patients.


Contact: Barbara Cohen-Kligerman

Related medicine news :

1. Elsevier launches Carpentiers reconstructive valve surgery book
2. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
3. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
4. Elsevier introduces innovative new pharmacology text
5. Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog
6. Clone Systems, Inc. Introduces On-Demand Penetration Testing Service
7. ORCS Web, Inc Introduces Windows Cloud Server
8. HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart
9. Cosmetic Peptides that Significantly Reduce Length and Depth of Wrinkles: Janet Sartin Introduces Advanced Anti-Wrinkle Peptide Serum for All Skin Types
10. Dxtra Introduces New Solid Stainless Steel Mouse Pad
11. OPTP Introduces the Pilates TRIADBALL™ Manual
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology: